Literature DB >> 20367554

Brain-specific angiogenesis inhibitor 2 (BAI2) may be activated by proteolytic processing.

Daisuke Okajima1, Gen Kudo, Hiroshi Yokota.   

Abstract

Brain-specific angiogenesis inhibitor 2 (BAI2) is a member of adhesion-G protein-coupled receptors (GPCRs). BAI2 is dominantly expressed in the brain and its physiological ligands and functions are still unclear. Adhesion-GPCRs, including BAI2, commonly have a long N-terminal extracellular region (ECR) containing the GPCR proteolysis site (GPS) and the cleavage of the ECR at the GPS domain is suspected to be important for their function. In this study, we analyzed the proteolytic processing of BAI2 and its activation mechanism. Several cleaved C-terminal fragments of BAI2 were identified in mouse hippocampus. We confirmed that mutation in the GPS domain caused inhibition of the proteolysis of BAI2, which indicated the possibility that BAI2 was cleaved at the GPS domain. The association of the ECR putatively cleaved at the GPS domain and the C-terminal seven-transmembrane (7TM) fragment was detected by co-immunoprecipitation. We also found that furin prohormone convertase cleaved BAI2 at another site in the ECR. Additionally, the C-terminal fragment cleaved at the GPS domain specifically activated the nuclear factor of activated T-cells (NFAT) pathway. These results suggest that BAI2 is a functional GPCR regulated by proteolytic processing and activates the NFAT pathway.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20367554     DOI: 10.3109/10799891003671139

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  33 in total

1.  Cell adhesion receptor GPR133 couples to Gs protein.

Authors:  Jens Bohnekamp; Torsten Schöneberg
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

Review 2.  Adhesion G Protein-Coupled Receptors: From In Vitro Pharmacology to In Vivo Mechanisms.

Authors:  Kelly R Monk; Jörg Hamann; Tobias Langenhan; Saskia Nijmeijer; Torsten Schöneberg; Ines Liebscher
Journal:  Mol Pharmacol       Date:  2015-05-08       Impact factor: 4.436

3.  Disease-associated extracellular loop mutations in the adhesion G protein-coupled receptor G1 (ADGRG1; GPR56) differentially regulate downstream signaling.

Authors:  Ayush Kishore; Randy A Hall
Journal:  J Biol Chem       Date:  2017-04-19       Impact factor: 5.157

Review 4.  Adhesion G protein-coupled receptors: signaling, pharmacology, and mechanisms of activation.

Authors:  Kevin J Paavola; Randy A Hall
Journal:  Mol Pharmacol       Date:  2012-07-20       Impact factor: 4.436

5.  Type IV collagen is an activating ligand for the adhesion G protein-coupled receptor GPR126.

Authors:  Kevin J Paavola; Harwin Sidik; J Bradley Zuchero; Michael Eckart; William S Talbot
Journal:  Sci Signal       Date:  2014-08-12       Impact factor: 8.192

Review 6.  The BAI subfamily of adhesion GPCRs: synaptic regulation and beyond.

Authors:  Jason R Stephenson; Ryan H Purcell; Randy A Hall
Journal:  Trends Pharmacol Sci       Date:  2014-03-15       Impact factor: 14.819

Review 7.  Adhesion G protein-coupled receptors in nervous system development and disease.

Authors:  Tobias Langenhan; Xianhua Piao; Kelly R Monk
Journal:  Nat Rev Neurosci       Date:  2016-07-28       Impact factor: 34.870

Review 8.  Mechanisms of adhesion G protein-coupled receptor activation.

Authors:  Alexander Vizurraga; Rashmi Adhikari; Jennifer Yeung; Maiya Yu; Gregory G Tall
Journal:  J Biol Chem       Date:  2020-08-06       Impact factor: 5.157

Review 9.  Function and therapeutic potential of G protein-coupled receptors in epididymis.

Authors:  Daolai Zhang; Yanfei Wang; Hui Lin; Yujing Sun; Mingwei Wang; Yingli Jia; Xiao Yu; Hui Jiang; Wenming Xu; Jin-Peng Sun; Zhigang Xu
Journal:  Br J Pharmacol       Date:  2020-10-29       Impact factor: 8.739

Review 10.  G Protein-Coupled Receptors in the Sweet Spot: Glycosylation and other Post-translational Modifications.

Authors:  Christoffer K Goth; Ulla E Petäjä-Repo; Mette M Rosenkilde
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.